INTERNATIONAL PATENT: ARGENX BV FILES APPLICATION FOR "METHODS FOR TREATING PRIMARY SJOGREN'S SYNDROME USING FCRN ANTAGONISTS"

GENEVA, Oct. 4 -- ARGENX BV (Industriepark Zwijnaarde 79052 Ghent) filed a patent application (PCT/IB2025/000125) for "METHODS FOR TREATING PRIMARY SJOGREN'S SYNDROME USING FCRN ANTAGONISTS" on Mar 26, 2025. With publication no. WO/2025/202714, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VAN MIDDENDORP, Joost Johannes (c/o Argenx BVIndustriepark Zwijnaarde 79052 Ghent), PAPADOPOULOU, Despoina (c/o Argenx BVIndustriepark Zwijnaarde 79052 Ghent), JACOBS, Julie (c/o Argenx BVIndustriepark Zwijnaarde 79052 Ghent), MEYVISC...